Physician profile
Roberto Caneva
NPI 1003444266
$10,217.10
in general payments reported to CMS, 2019-2025
15 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.10 · 2021: $769 · 2022: $5,716 · 2023: $3,160 · 2024: $219 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,549 · Travel and Lodging: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,548.71 |
| Travel and Lodging | $1,169.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,780.62 | 2021-2025 | Augment Injectable, Hoffmann, Variax |
| Medwest Associates | $3,650.33 | 2022-2023 | |
| Integra Lifesciences Corporation | $572.65 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $433.28 | 2022-2023 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $354.05 | 2023-2025 | Grafix, Collagenase Santyl, Versajet |
| Horizon Therapeutics Plc | $288.96 | 2021-2023 | Krystexxa |
| Kerecis Limited | $253.01 | 2021-2022 | |
| Depuy Synthes Sales INC. | $208.34 | 2020-2022 | |
| Organogenesis INC. | $181.63 | 2021-2025 | Apligraf |
| Zimmer Biomet Holdings, INC. | $149.97 | 2021 | |
| Paratek Pharmaceuticals, INC. | $125.70 | 2021-2022 | |
| Medline Industries LP | $114.38 | 2021-2023 | |
| Lightbody Medical Technologies INC | $51.58 | 2024 | |
| Fusion Orthopedics USA, LLC | $38.38 | 2024 | |
| Lifenet Health | $14.22 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Caneva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.